J
Jack Stone
Researcher at University of Bristol
Publications - 48
Citations - 2792
Jack Stone is an academic researcher from University of Bristol. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 13, co-authored 35 publications receiving 1788 citations.
Papers
More filters
Journal ArticleDOI
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review
Louisa Degenhardt,Amy Peacock,Samantha Colledge,Janni Leung,Jason Grebely,Peter Vickerman,Jack Stone,Evan B Cunningham,Adam Trickey,Kostyantyn Dumchev,Michael T. Lynskey,Paul Griffiths,Richard P. Mattick,Matthew Hickman,Sarah Larney +14 more
TL;DR: A global multistage systematic review of sharing of equipment used for injecting drug use (IDU) identified evidence of IDU in more countries than in 2008, with the new countries largely consisting of low-income and middle-income countries in Africa.
Journal ArticleDOI
Public health and international drug policy
Joanne Csete,Adeeba Kamarulzaman,Michel D. Kazatchkine,Frederick L. Altice,Marek Balicki,Julia Buxton,Javier A. Cepeda,Megan Comfort,Eric Goosby,João Goulão,Carl L. Hart,Thomas Kerr,Alejandro Madrazo Lajous,Stephen R. Lewis,Natasha K. Martin,Daniel Mejía,Adriana Camacho,David Scott Mathieson,Isidore Obot,Adeolu Ogunrombi,Susan G. Sherman,Jack Stone,Nandini Vallath,Peter Vickerman,Tomáš Zábranský,Chris Beyrer +25 more
TL;DR: The Johns Hopkins-Lancet Commission on Drug Policy and Health as mentioned in this paper examined the emerging scientific evidence on public health issues arising from drug control policy and to inform and encourage a central focus on health evidence and outcomes in drug-policy debates, such as the important deliberations of the 2016 UNGASS on drugs.
Journal ArticleDOI
Global patterns of opioid use and dependence: harms to populations, interventions, and future action.
Louisa Degenhardt,Jason Grebely,Jack Stone,Matthew Hickman,Peter Vickerman,Brandon D.L. Marshall,Julie Bruneau,Frederick L. Altice,Graeme Henderson,Afarin Rahimi-Movaghar,Sarah Larney +10 more
TL;DR: Opioid agonist treatment can be highly effective in reducing illicit opioid use and improving multiple health and social outcomes, by reducing overall mortality and key causes of death, including overdose, suicide, HIV, hepatitis C virus, and other injuries.
Journal ArticleDOI
The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia
Frederick L. Altice,Lyuba Azbel,Jack Stone,Ellen Brooks-Pollock,Pavlo Smyrnov,Sergii Dvoriak,Faye S. Taxman,Nabila El-Bassel,Natasha K. Martin,Natasha K. Martin,Robert E. Booth,Heino Stöver,Kate Dolan,Peter Vickerman +13 more
TL;DR: Interventions that reduce incarceration itself and effectively intervene with prisoners to screen, diagnose, and treat addiction and HIV, hepatitis C virus, and tuberculosis are urgently needed to stem the multiple overlapping epidemics concentrated in prisons.
Journal ArticleDOI
Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs
Jason Grebely,Sarah Larney,Amy Peacock,Samantha Colledge,Janni Leung,Janni Leung,Matthew Hickman,Peter Vickerman,Sarah Blach,Evan B Cunningham,Kostyantyn Dumchev,Michael T. Lynskey,Jack Stone,Adam Trickey,Homie Razavi,Richard P. Mattick,Michael Farrell,Gregory J. Dore,Louisa Degenhardt +18 more
TL;DR: Although, globally, 39.2% of people with recent injecting drug use are living with hepatitis C virus (HCV) and 8.5% of all HCV infections occur globally among people with recently injected drug use, there is wide variation among countries and regions.